Valeant Pharmaceuticals International

As of September 28, 2010, Valeant Pharmaceuticals International was acquired by Valeant Pharmaceuticals International, Inc. Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products. It primarily offers specialty pharmaceutical and over-the-counter (OTC) products in the areas of dermatology and neurology therapeutic classes. The company’s products include Efudex/Efudix for the treatment of multiple actinic or solar keratoses and superficial basal cell carcinoma; Acanya and Atralin gels for the treatment of acne vulgaris; Kinerase, a range of OTC and prescription cosmetic products; Nyal, a range of tablets, liquids, and nasal sprays to treat cough, cold, flu, sinus, and hayfever symptoms; and topical OTC products under the tradenames Dermaveen, Dr. LeWinn’s, and Dr. Renaud. In addition, the company provides branded generic products in antibiotics, antifungal medications, and diabetic therapies in Europe; and antibacterials, vitamin deficiency, and dermatology in Latin America. The company was founded in 1960 and is based in Aliso Viejo, California.